
The episode discusses HPQ Silicon's partnership with Novacium and GH Technologies to explore commercial opportunities for advanced lithium-ion batteries in the Asia Pacific market.
When a company moves from lab validation to commercial conversations, the phone does not just ring once. It starts ringing from multiple directions. HPQ Silicon’s technology partner Novacium has signed a non-binding, non-exclusive Letter of Intent with GH Technologies, a Hong Kong based B2B distributor, to evaluate potential commercial opportunities for high capacity GEN4 lithium-ion cells in Asia Pacific markets. The LOI covers Novacium’s GEN4 18650 and 21700 formats, along with other lithium-ion batteries built on Novacium’s GEN4 silicon anode technology. Asia Pacific represents more than 57% of global demand for cylindrical lithium-ion cells, making it one of the most important regions for battery commercialization. GH Technologies entered the LOI following its evaluation of Novacium GEN4 cells, including reported capacity exceeding 6,600 mAh, reported energy density of 319.9 Wh/kg, and international certifications including IEC 62133, UL 1642, and UN 38.3. A related Novacium LinkedIn post added another layer of context, referencing a potential partnership value of more than US$30 million over 36 months. That figure should be understood as potential value, not confirmed…
Organizations: HPQ Silicon, Novacium, GH Technologies, ENDURA+
Products: GEN4 lithium-ion cells, GEN4 18650, 21700 formats, silicon anode technology
Places: Asia Pacific
Explore listener stats, chart rankings, contacts and more on the AGORACOM Small Cap CEO Interviews podcast page.